These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 26642940)
1. Heat shock protein 90 inhibitors induce functional inhibition of human natural killer cells in a dose-dependent manner. Huyan T; Li Q; Dong DD; Yang H; Zhang J; Huang QS; Yin DC; Shang P Immunopharmacol Immunotoxicol; 2016; 38(2):77-86. PubMed ID: 26642940 [TBL] [Abstract][Full Text] [Related]
2. Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors. Centenera MM; Gillis JL; Hanson AR; Jindal S; Taylor RA; Risbridger GP; Sutherland PD; Scher HI; Raj GV; Knudsen KE; Yeadon T; ; Tilley WD; Butler LM Clin Cancer Res; 2012 Jul; 18(13):3562-70. PubMed ID: 22573351 [TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity. Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844 [TBL] [Abstract][Full Text] [Related]
4. Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells. Kim SH; Cho YK; Huh JH; Kang JG; Ihm SH; Choi MG; Lee SJ Anticancer Res; 2020 Nov; 40(11):6137-6150. PubMed ID: 33109551 [TBL] [Abstract][Full Text] [Related]
5. Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction. Stingl L; Stühmer T; Chatterjee M; Jensen MR; Flentje M; Djuzenova CS Br J Cancer; 2010 May; 102(11):1578-91. PubMed ID: 20502461 [TBL] [Abstract][Full Text] [Related]
6. HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells. Lee DH; Sung KS; Bartlett DL; Kwon YT; Lee YJ Cell Signal; 2015 Feb; 27(2):293-305. PubMed ID: 25446253 [TBL] [Abstract][Full Text] [Related]
7. Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma. Chen MH; Lin KJ; Yang WL; Kao YW; Chen TW; Chao SC; Chang PM; Liu CY; Tzeng CH; Chao Y; Chen MH; Yeh CN; Huang CY Cancer; 2013 Jan; 119(2):293-303. PubMed ID: 22810956 [TBL] [Abstract][Full Text] [Related]
8. Redefining the Phenotype of Heat Shock Protein 90 (Hsp90) Inhibitors. Wang Y; Koay YC; McAlpine SR Chemistry; 2017 Feb; 23(9):2010-2013. PubMed ID: 27862436 [TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells. Bae J; Munshi A; Li C; Samur M; Prabhala R; Mitsiades C; Anderson KC; Munshi NC J Immunol; 2013 Feb; 190(3):1360-71. PubMed ID: 23293352 [TBL] [Abstract][Full Text] [Related]
10. Sensitization of multidrug-resistant human cancer cells to Hsp90 inhibitors by down-regulation of SIRT1. Kim HB; Lee SH; Um JH; Oh WK; Kim DW; Kang CD; Kim SH Oncotarget; 2015 Nov; 6(34):36202-18. PubMed ID: 26416354 [TBL] [Abstract][Full Text] [Related]
11. The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells. Walsby EJ; Lazenby M; Pepper CJ; Knapper S; Burnett AK Br J Haematol; 2013 Apr; 161(1):57-67. PubMed ID: 23356405 [TBL] [Abstract][Full Text] [Related]
12. BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90. Lundgren K; Zhang H; Brekken J; Huser N; Powell RE; Timple N; Busch DJ; Neely L; Sensintaffar JL; Yang YC; McKenzie A; Friedman J; Scannevin R; Kamal A; Hong K; Kasibhatla SR; Boehm MF; Burrows FJ Mol Cancer Ther; 2009 Apr; 8(4):921-9. PubMed ID: 19372565 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo. Schwock J; Pham NA; Cao MP; Hedley DW Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866 [TBL] [Abstract][Full Text] [Related]
14. 17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy. Karkoulis PK; Stravopodis DJ; Voutsinas GE Tumour Biol; 2016 May; 37(5):6861-73. PubMed ID: 26662567 [TBL] [Abstract][Full Text] [Related]
15. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer. Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988 [TBL] [Abstract][Full Text] [Related]
16. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation. Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706 [TBL] [Abstract][Full Text] [Related]
17. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells. Schilling D; Kühnel A; Tetzlaff F; Konrad S; Multhoff G Cancer Immunol Immunother; 2015 May; 64(5):599-608. PubMed ID: 25854583 [TBL] [Abstract][Full Text] [Related]
18. BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy. Yin X; Zhang H; Lundgren K; Wilson L; Burrows F; Shores CG Int J Cancer; 2010 Mar; 126(5):1216-25. PubMed ID: 19662650 [TBL] [Abstract][Full Text] [Related]
19. SNX-2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells. Wang SX; Ju HQ; Liu KS; Zhang JX; Wang X; Xiang YF; Wang R; Liu JY; Liu QY; Xia M; Xing GW; Liu Z; Wang YF Biosci Biotechnol Biochem; 2011; 75(8):1540-5. PubMed ID: 21821931 [TBL] [Abstract][Full Text] [Related]
20. The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors. Voruganti S; Lacroix JC; Rogers CN; Rogers J; Matts RL; Hartson SD J Proteome Res; 2013 Aug; 12(8):3697-706. PubMed ID: 23763277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]